Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 30

1.

Prevalence of "unclassified" HPV genotypes among women with abnormal cytology.

Annunziata C, Stellato G, Greggi S, Sanna V, Curcio MP, Losito S, Botti G, Buonaguro L, Buonaguro FM, Tornesello ML.

Infect Agent Cancer. 2018 Jul 24;13:26. doi: 10.1186/s13027-018-0199-0. eCollection 2018.

2.

The role of sensing peptides in the cross-talk between microbiota and human cancer cells.

Tornesello AL, Buonaguro L, Tornesello ML, Buonaguro FM.

Mini Rev Med Chem. 2018 Jul 12. doi: 10.2174/1389557518666180713112119. [Epub ahead of print]

PMID:
30003859
3.

Human Oncoviruses and p53 Tumor Suppressor Pathway Deregulation at the Origin of Human Cancers.

Tornesello ML, Annunziata C, Tornesello AL, Buonaguro L, Buonaguro FM.

Cancers (Basel). 2018 Jun 22;10(7). pii: E213. doi: 10.3390/cancers10070213. Review.

4.

The Role of Circulating Free DNA and MicroRNA in Non-Invasive Diagnosis of HBV- and HCV-Related Hepatocellular Carcinoma.

Pezzuto F, Buonaguro L, Buonaguro FM, Tornesello ML.

Int J Mol Sci. 2018 Mar 28;19(4). pii: E1007. doi: 10.3390/ijms19041007. Review.

5.

Role of gut microbiota and oxidative stress in the progression of non-alcoholic fatty liver disease to hepatocarcinoma: Current and innovative therapeutic approaches.

Borrelli A, Bonelli P, Tuccillo FM, Goldfine ID, Evans JL, Buonaguro FM, Mancini A.

Redox Biol. 2018 May;15:467-479. doi: 10.1016/j.redox.2018.01.009. Epub 2018 Feb 3. Review.

6.

New Insights in the Design of Bioactive Peptides and Chelating Agents for Imaging and Therapy in Oncology.

Tornesello AL, Buonaguro L, Tornesello ML, Buonaguro FM.

Molecules. 2017 Aug 2;22(8). pii: E1282. doi: 10.3390/molecules22081282. Review.

7.

HCV-related liver and lymphoproliferative diseases: association with polymorphisms of IL28B and TLR2.

De Re V, De Zorzi M, Caggiari L, Lauletta G, Tornesello ML, Fognani E, Miorin M, Racanelli V, Quartuccio L, Gragnani L, Russi S, Pavone F, Ghersetti M, Costa EG, Casarin P, Bomben R, Mazzaro C, Basaglia G, Berretta M, Vaccher E, Izzo F, Buonaguro FM, De Vita S, Zignego AL, De Paoli P, Dolcetti R.

Oncotarget. 2016 Jun 21;7(25):37487-37497. doi: 10.18632/oncotarget.9303.

8.

Solid Phase Formylation of N-Terminus Peptides.

Tornesello AL, Sanseverino M, Buonaguro FM.

Molecules. 2016 Jun 4;21(6). pii: E736. doi: 10.3390/molecules21060736.

9.

Candidate Soluble Immune Mediators in Young Women with High-Risk Human Papillomavirus Infection: High Expression of Chemokines Promoting Angiogenesis and Cell Proliferation.

Zanotta N, Tornesello ML, Annunziata C, Stellato G, Buonaguro FM, Comar M.

PLoS One. 2016 Mar 18;11(3):e0151851. doi: 10.1371/journal.pone.0151851. eCollection 2016.

10.

Impairment of T cell development and acute inflammatory response in HIV-1 Tat transgenic mice.

Fiume G, Scialdone A, Albano F, Rossi A, Tuccillo FM, Rea D, Palmieri C, Caiazzo E, Cicala C, Bellevicine C, Falcone C, Vecchio E, Pisano A, Ceglia S, Mimmi S, Iaccino E, de Laurentiis A, Pontoriero M, Agosti V, Troncone G, Mignogna C, Palma G, Arra C, Mallardo M, Buonaguro FM, Scala G, Quinto I.

Sci Rep. 2015 Sep 7;5:13864. doi: 10.1038/srep13864.

11.

Correction: Genetic Diversity of the KIR/HLA System and Susceptibility to Hepatitis C Virus-Related Diseases.

De Re V, Caggiari L, De Zorzi M, Repetto O, Zignego AL, Izzo F, Tornesello ML, Buonaguro FM, Mangia A, Sansonno D, Racanelli V, De Vita S, Pioltelli P, Vaccher E, Beretta M, Mazzaro C, Libra M, Gini A, Zucchetto A, Cannizzaro R, De Paoli P.

PLoS One. 2015 May 15;10(5):e0128849. doi: 10.1371/journal.pone.0128849. eCollection 2015. No abstract available.

12.

Genetic diversity of the KIR/HLA system and susceptibility to hepatitis C virus-related diseases.

De Re V, Caggiari L, De Zorzi M, Repetto O, Zignego AL, Izzo F, Tornesello ML, Buonaguro FM, Mangia A, Sansonno D, Racanelli V, De Vita S, Pioltelli P, Vaccher E, Berretta M, Mazzaro C, Libra M, Gini A, Zucchetto A, Cannizzaro R, De Paoli P.

PLoS One. 2015 Feb 20;10(2):e0117420. doi: 10.1371/journal.pone.0117420. eCollection 2015. Erratum in: PLoS One. 2015;10(5):e0128849. Beretta, Massimiliano [corrected to Berretta, Massimiliano].

13.

The XIX century smallpox prevention in Naples and the risk of transmission of human blood-related pathogens.

Buonaguro FM, Tornesello ML, Buonaguro L.

J Transl Med. 2015 Jan 27;13:33. doi: 10.1186/s12967-015-0400-9.

14.

Impact of immunogenetic IL28B polymorphism on natural outcome of HCV infection.

De Re V, Gragnani L, Fognani E, Piluso A, Izzo F, Mangia A, Crovatto M, Gava G, Casarin P, Sansonno D, Racanelli V, De Vita S, Pioltelli P, Caggiari L, De Zorzi M, Berretta M, Gini A, Zucchetto A, Buonaguro FM, De Paoli P, Zignego AL.

Biomed Res Int. 2014;2014:710642. doi: 10.1155/2014/710642. Epub 2014 Feb 26.

15.

Aberrant glycosylation as biomarker for cancer: focus on CD43.

Tuccillo FM, de Laurentiis A, Palmieri C, Fiume G, Bonelli P, Borrelli A, Tassone P, Scala I, Buonaguro FM, Quinto I, Scala G.

Biomed Res Int. 2014;2014:742831. doi: 10.1155/2014/742831. Epub 2014 Feb 13. Review.

16.

CDK/CCN and CDKI alterations for cancer prognosis and therapeutic predictivity.

Bonelli P, Tuccillo FM, Borrelli A, Schiattarella A, Buonaguro FM.

Biomed Res Int. 2014;2014:361020. doi: 10.1155/2014/361020. Epub 2014 Jan 29. Review.

17.

Human Papillomavirus Infection and Cervical Neoplasia among Migrant Women Living in Italy.

Tornesello ML, Giorgi Rossi P, Buonaguro L, Buonaguro FM; HPV Prevalence Italian Working Group.

Front Oncol. 2014 Feb 20;4:31. doi: 10.3389/fonc.2014.00031. eCollection 2014.

18.

The functional role of MnSOD as a biomarker of human diseases and therapeutic potential of a new isoform of a human recombinant MnSOD.

Borrelli A, Schiattarella A, Bonelli P, Tuccillo FM, Buonaguro FM, Mancini A.

Biomed Res Int. 2014;2014:476789. doi: 10.1155/2014/476789. Epub 2014 Jan 6.

19.

Cancer-associated CD43 glycoforms as target of immunotherapy.

Tuccillo FM, Palmieri C, Fiume G, de Laurentiis A, Schiavone M, Falcone C, Iaccino E, Galandrini R, Capuano C, Santoni A, D'Armiento FP, Arra C, Barbieri A, Dal Piaz F, Venzon D, Bonelli P, Buonaguro FM, Scala I, Mallardo M, Quinto I, Scala G.

Mol Cancer Ther. 2014 Mar;13(3):752-62. doi: 10.1158/1535-7163.MCT-13-0651. Epub 2013 Dec 19.

20.

Oncolytic virus therapies.

Buonaguro FM, Tornesello ML, Izzo F, Buonaguro L.

Pharm Pat Anal. 2012 Nov;1(5):621-7. doi: 10.4155/ppa.12.65. Review.

PMID:
24236929

Supplemental Content

Loading ...
Support Center